B81 Profarm Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth 31.91%
- Profit Growth 29.21%
- Ebitda -30.13%
- Net Worth -82.91%
- Total Assets 0.19%
About B81 Profarm Solutions
B81 Profarm Solutions Private Limited (BPSPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 October 2018 (Six years and four months 8 days old ). Its registered office is in Krishna, Andhra Pradesh, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Naga Katiki, Surendranath Bommireddy, Malireddy Reddy, and One other member serve as directors at the Company.
Company Details
-
Location
Krishna, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999AP2018PTC109417
-
Company No.
109417
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Oct 2018
-
Date of AGM
29 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at B81 Profarm Solutions?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naga Katiki
|
Director | 03-Oct-2018 | Current |
|
Surendranath Bommireddy
|
Director | 03-Oct-2018 | Current |
|
Malireddy Reddy
|
Director | 03-Oct-2018 | Current |
|
Nageswara Kakarla
|
Director | 03-Oct-2018 | Current |
Financial Performance of B81 Profarm Solutions.
B81 Profarm Solutions Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 31.91% increase. The company also saw a substantial improvement in profitability, with a 29.21% increase in profit. The company's net worth observed a substantial decline by a decrease of 82.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B81 Profarm Solutions?
Unlock access to B81 Profarm Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sharpedge Enterprise Solutions Private LimitedNaga Katiki is a mutual person
-
Bio Fresh Exim (India) Private Limited
Nageswara Kakarla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at B81 Profarm Solutions?
Unlock and access historical data on people associated with B81 Profarm Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B81 Profarm Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B81 Profarm Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.